Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy–Naïve Women With Hormone Receptor–Positive Advanced Breast Cancer ... MSD, SITC/ACCC, Melanoma Research Foundation, Melanoma Research ...

Patients may require life-long monitoring and a collaborative engagement with subspecialists to keep well in the long -term,” ...

This trial is looking at adding SCIB1 or iSCIB1+ to nivolumab and ipilimumab for ... to pembrolizumab for melanoma. It is for people whose melanoma has grown into surrounding tissues or spread ...

The trial demonstrated that bi-immunotherapy with ipilimumab and nivolumab administered before ... has been approved as a first-line treatment for advanced melanoma without brain metastases ...

During a Case-Based Roundtable® event, Thach-Giao Truong, MD, discussed how data from the CheckMate-067 and RELATIVITY-047 ...

Some stage 3 melanomas cannot be removed with surgery. Doctors treat these with the same targeted cancer drugs and immunotherapy they use for advanced melanoma. Doctors use targeted cancer drugs or ...

and increase the proportion of patients who respond to immunotherapy. The phase 2 trial will recruit patients with advanced melanoma that can’t be treated with surgery who are refractory to or ...

Immunotherapy nevertheless ... in nearly 60% of people with advanced melanoma. The BBC reports that an international trial on 945 patients found treatment with ipilimumab and nivolumab stopped ...

A new skin cancer treatment has been found ... A decade-long study investigated two immunotherapy drugs, ipilimumab and ...

An immunotherapy combination for advanced, highly mutated colorectal cancer (CRC) significantly slowed disease progression versus a single drug, according to a randomized study. Median ...